Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4 Purity >99,5% EE >99,5%
Panganteur Patali Pasokan Kimia Ruifu
CAS 361442-04-8
CAS 945667-22-1
(Urang Sunda)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]heksana-2-Asam Karboksilat tert-Butil Éster CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Ngaran Kimia | Boc-3-Hydroxy-1-Adamantyl-D-Glycine |
sinonim | (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-Hydroxyadamantan-1-yl)Asam asétat |
Nomer CAS | 361442-00-4 |
Nomer CAT | RF-PI1989 |
Status Saham | Dina Stok, Skala Produksi Nepi ka Ton |
Formula Molekul | C17H27NO5 |
Beurat Molekul | 325.40 |
Titik didih | 497,3 ± 20,0 ℃ |
Kapadetan | 1.296 |
merek | Kimia Ruifu |
Barang | spésifikasi |
Penampilan | Bubuk kristalin bodas atanapi Pareum-Bodas |
Cai (KF) | <0,50% |
Leungitna dina Drying | <1,00% |
Résidu on Ignition | <0,50% |
Najis Tunggal | <0,50% |
Total Kotoran | <0,50% |
EE | >99,5% |
Kasucian | >99,5% |
Spéktrum Infrabeureum | Conforms kana Struktur |
Standar tés | Standar Perusahaan |
Pamakéan | Panganteur Farmasi |
Bungkusan: Botol, kantong Aluminium foil, 25kg / Karton Drum, atawa nurutkeun sarat customer urang
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap
Boc-3-Hydroxy-1-Adamantyl-D-Glycine (CAS: 361442-00-4) mangrupa panganteur API (CAS: 361442-04-8).API (CAS: 361442-04-8)mangrupakeun inhibitor malik potent tur selektif dipeptidyl peptidase-4, nu keur dimekarkeun pikeun pengobatan diabetes tipe 2.Éta kaserep gancang saatos administrasi oral sareng gaduh profil farmakokinetik anu cocog sareng dosis sakali sapoé.Ieu mangrupakeun dipeptidyl peptidase-4 (DPP-4) inhibitor antidiabetic pikeun pengobatan diabetes tipe 2.Inhibitor DPP-4 mangrupikeun sanyawa kelas anu dianggo ku mangaruhan tindakan hormon alami dina awak anu disebut incretins.IeuHal ieu dipaké babarengan jeung diet jeung latihan pikeun ngaronjatkeun kontrol gula getih dina sawawa jeung diabetes tipe 2.Éta henteu kanggo ngubaran diabetes tipe 1.IeuKadang-kadang dianggo digabungkeun sareng pangobatan diabetes anu sanés.Éta kahontal ku gawé babarengan AstraZeneca sareng Bristol-Myers Squibb Company sareng milik inhibitor DPP-IV.